Skip to main content

COVID-19

By Sara Mageit | 07:58 am | March 17, 2021
Member States and the European Commission have set up a service to allow national apps to talk to each other. 
By HIMSS TV | 10:20 am | March 16, 2021
Dr. Azizi Seixas explains why communities of color are at greater risk of suffering severe consequences, including secondary ones, from the pandemic.
By Rachel McArthur | 07:54 am | March 16, 2021
The technology by Singaporean company, Breathonix can reportedly produce results within 60 seconds by detecting Volatile Organic Compounds [VOCs] in a patient’s exhaled breath. 
By Sara Mageit | 06:46 am | March 16, 2021
The funding will go towards expanding mental health provision for post-pandemic Britain.
By Sophie Porter | 03:49 am | March 16, 2021
Rokote Laboratories are seeking investment for the vaccine and are already in discussions about clinical trials although no date has been set.
By Laura Lovett | 12:38 pm | March 15, 2021
CEO Mark Zuckerberg also announced that the company will be using WhatsApp's chatbots to help with vaccine registration. 
By Sara Mageit | 09:18 am | March 15, 2021
The analyser is part of an assessment of the AI-based ‘CURIAL’ test to screen for COVID-19 in patients.
By Paulus Torkki | 02:59 am | March 10, 2021
Value-based care implies radical, even disruptive changes to the current practice, say Paulus Torkki, associate professor of healthcare operations management at University of Helsinki and Marianna Imenokhoeva, founder of LinktoMedicine and HIMSS Future50 Leader. 
By Sara Mageit | 10:36 am | March 08, 2021
Study finds nasal spray delivery offers "many benefits" over traditional approaches to vaccine administration.
By Dave Muoio | 05:36 pm | March 05, 2021
The system delivers its results to a companion app in about 20 minutes, according to the agency.